15 May 2019
Pharmac delays decision on funding life-prolonging drugs
A long-time advocate for breast cancer patients has died, as Pharmac's drug advisory panel again delays its decision on funding life-prolonging cancer treatments Kadcyla and Ibrance. Alex Perrottet reports.